Company: INMB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001213900-25-041072
Chunk: 110

Company: Inmune Bio, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 2
Chunk 110
---
RL and contained in Exhibit 101).

28

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

    INmune Bio Inc. 

    Date: May 8, 2025
    By:
    /s/
    Raymond J. Tesi

    Raymond J. Tesi

    Chief Executive Officer

    (Principal Executive Officer)

    Date: May 8, 2025 
    By:
    /s/ David J. Moss

    David J. Moss

    Chief Financial Officer, Treasurer, Secretary

    (Principal Financial and Accounting Officer)

29

0001711754
false
Q1
--12-31

    0001711754

    2025-01-01
    2025-03-31

    0001711754

    2025-05-08

    0001711754

    2025-03-31

    0001711754

    2024-12-31

    0001711754
    
      us-gaap:RelatedPartyMember

    2025-03-31

    0001711754
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0001711754

    2024-01-01
    2024-03-31

    0001711754
    
      us-gaap:CommonStockMember

    2024-12-31

    0001711754
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-12-31

    0001711754
    
      us-gaap:AccumulatedOtherComprehensiveIncomeMember

    2024-12-31

    0001711754
    
      us-gaap:RetainedEarningsMember

    2024-12-31

    0001711754
    
      us-gaap:CommonStockMember

    2025-01-01
    2025-03-31

    0001711754
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-01-01
    2025-03-31

    0001711754